The case for indefinite treatment is strongest in this population
Off-label use should be approached cautiously and only under specialist guidance
Data from only three groups (vehicle, AMG 133 0.25 mg kg 1 and AMG 133 0.75 mg kg 1 ) are reported and discussed in this publication
doi: 10.3389/fphys.2022.1093388 Received 08 November 2022 Accepted 22 December 2022 Published 09 January 2023 Volume 13 - 2022 Edited by Lisa Li, The University of Iowa, United States Reviewed by Krishnamurthy Nakuluri, The University of Iowa, United States Jerzy Beltowski, Medical University of Lublin, Poland Updates Copyright 2023 Strutynska, Goshovska, Mys, Strutynskyi, Luchkova, Fedichkina, Okhai, Korkach and Sagach
That's over half of Part D enrollees